BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25772076)

  • 1. Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal.
    Cortese R; Pontrelli G; Mogavero MP; Dicuonzo F; Tortorella C
    Neurol Sci; 2015 Aug; 36(8):1515-6. PubMed ID: 25772076
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient lesion in the splenium of the corpus callosum due to carbamazepine.
    Güven H; Delibaş S; Comoğlu SS
    Turk Neurosurg; 2008 Jul; 18(3):264-70. PubMed ID: 18814116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible splenial lesion in the corpus callosum following rapid withdrawal of carbamazepine after neurosurgical decompression for trigeminal neuralgia.
    Mori H; Maeda M; Takanashi J; Kunimatsu A; Matsushima N; Suzuki H; Saito N; Ohtomo K
    J Clin Neurosci; 2012 Aug; 19(8):1182-4. PubMed ID: 22349431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review.
    Jing C; Sun L; Wang Z; Chu C; Lin W
    J Int Med Res; 2018 Mar; 46(3):1277-1281. PubMed ID: 29322880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient splenial lesion of the corpus callosum after acute withdrawal of antiepileptic drug: a case report.
    Honda K; Nishimiya J; Sato H; Munakata M; Kamada M; Iwamura A; Nemoto H; Sakamoto T; Yuasa T
    Magn Reson Med Sci; 2006 Dec; 5(4):211-5. PubMed ID: 17332713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible splenial lesion following rapid withdrawal of carbamazepine.
    Kim TW; Park IS; Kim JS
    Can J Neurol Sci; 2014 Jul; 41(4):504-5. PubMed ID: 24878477
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbamazepine and rebound mania.
    Jess GE; Smith DJ; Mackenzie C; Crawford C
    Am J Psychiatry; 2004 Nov; 161(11):2132-3. PubMed ID: 15514420
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible focal splenial lesions in facial pain patients treated with antiepileptic drugs: case report and review of the literature.
    Ruscheweyh R; Marziniak M; Evers S
    Cephalalgia; 2009 May; 29(5):587-90. PubMed ID: 19055509
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute psychosis associated with abrupt withdrawal of carbamazepine following intoxication.
    Darbar D; Connachie AM; Jones AM; Newton RW
    Br J Clin Pract; 1996 Sep; 50(6):350-1. PubMed ID: 8983329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.
    Lu PL; Hodes JF; Zheng X; Hu XY
    Intern Med; 2020 Oct; 59(20):2471-2480. PubMed ID: 32611957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transient focal lesion in the splenium of the corpus callosum caused by carbamazepine].
    Takeuchi S; Takasato Y; Masaoka H; Hayakawa T; Otani N; Yoshino Y; Yatsushige H
    Brain Nerve; 2007 Mar; 59(3):286-7. PubMed ID: 17370655
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine.
    Narita H; Odawara T; Kawanishi C; Kishida I; Iseki E; Kosaka K
    Psychiatry Clin Neurosci; 2003 Oct; 57(5):550-1. PubMed ID: 12950714
    [No Abstract]   [Full Text] [Related]  

  • 13. A child with three episodes of reversible splenial lesion.
    Kouga T; Iai M; Yamashita S; Aida N; Takanashi J; Osaka H
    Neuropediatrics; 2013 Aug; 44(4):199-202. PubMed ID: 23254571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal.
    Gürtler S; Ebner A; Tuxhorn I; Ollech I; Pohlmann-Eden B; Woermann FG
    Neurology; 2005 Oct; 65(7):1032-6. PubMed ID: 16217055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal reaction of carbamazepine after neurovascular decompression for trigeminal neuralgia: a preliminary study.
    Chen MJ; Zhang WJ; Guo ZL; Zhang WH; Chai Y; Li YW
    J Neurol Sci; 2014 Mar; 338(1-2):43-5. PubMed ID: 24387898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI findings of a postpartum patient with reversible splenial lesion syndrome (RESLES).
    Altunkas A; Aktas F; Ozmen Z; Albayrak E; Almus F
    Acta Neurol Belg; 2016 Sep; 116(3):347-9. PubMed ID: 26690940
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible corpus callosum splenial lesion due to steroid therapy.
    Aksu B; Kurtcan S; Alkan A; Aralasmak A; Oktem F
    J Neuroimaging; 2015; 25(3):501-4. PubMed ID: 24945326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a reversible splenial lesion a sign of encephalopathy?
    Tsuji M; Yoshida T; Miyakoshi C; Haruta T
    Pediatr Neurol; 2009 Aug; 41(2):143-5. PubMed ID: 19589466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible splenial lesion syndrome (RESLES): what's in a name?
    Garcia-Monco JC; Cortina IE; Ferreira E; Martínez A; Ruiz L; Cabrera A; Beldarrain MG
    J Neuroimaging; 2011 Apr; 21(2):e1-14. PubMed ID: 18681931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Reversible Corpus Callosum Splenium Lesion in A Neonate with Hypoglycemia and Seizure.
    Lin YJ; Ho CS; Chiu NC; Tseng HS; Hsu CH; Huang JK
    Acta Neurol Taiwan; 2015 Mar; 24(1):15-8. PubMed ID: 26179685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.